CXCR7 (RDC1) promotes breast and lung tumor growth <i>in vivo</i> and is expressed on tumor-associated vasculature
Zhenhua Miao(ChemoCentryx (United States)), Thomas J. Schall(ChemoCentryx (United States)), Aidas Nasevicius, Kathryn E. Luker(Imaging Center), Gary D. Luker(University of Michigan), Celina G. Kleer(University of Michigan), Alnawaz Rehemtulla(University of Michigan–Ann Arbor), Mahaveer S. Bhojani(Radiation Oncology Associates), Rob Berahovich(ChemoCentryx (United States)), Maureen Howard(Stanford University), Bretton C. Summers(ChemoCentryx (United States)), Jeffrey J. Essner(Iowa State University)
Cited by 532
Related Papers
Identification of a major co-receptor for primary isolates of HIV-1
|Nature|1996|3.7k
A new class of membrane-bound chemokine with a CX3C motif
|Nature|1997|2k
Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and Adhesion
|Cell|1997|1.5k
Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES
|Nature|1990|1.4k
A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development
|The Journal of Experimental Medicine|2006|1.3k